Cervical cancer screening among women who gave birth in the US-Mexico border region, 2005: the Brownsville-Matamoros Sister City Project for Women's Health.
BACKGROUND
The objective of this study was to examine correlates of ever having had a Papanicolaou (Pap) test among women who recently delivered a live infant and who resided near the US-Mexico border.


METHODS
This cross-sectional study included women who delivered a live infant in Matamoros, Mexico (n = 488) and Cameron County, Texas (n = 453). Women were interviewed in the hospital before discharge between August 21 and November 9, 2005. Multivariable logistic regression was used to estimate the odds of ever having had a Pap test.


RESULTS
Significantly fewer Matamoros women (62.1%) than Cameron County women (95.7%) reported ever having had a Pap test. Only 12% of Matamoros women said they received their most recent Pap test during prenatal care, compared with nearly 75% of Cameron County women. After adjusting for potential confounders, the odds of ever having had a Pap test were 7.41 times greater in Cameron County than in Matamoros (95% confidence interval, 4.07-13.48).


CONCLUSIONS
The Healthy Border 2010 goals are to cut cervical cancer mortality by 20% to 30% in the border region. The significant difference in Pap test prevalence among our survey respondents may reflect that routine prenatal Pap testing is more common in the United States than in Mexico. Because women who are receiving prenatal care have increased interaction with health care providers, Matamoros providers may need to be educated about the need to screen for cervical cancer during this time.
Castrucci
Brian C
BC
Texas Department of State Health Services, 1100 West 49th St, Austin, TX 78756, USA. brian.castrucci@dshs.state.tx.us
Echegollen Guzmán
Alonso
A
Saraiya
Mona
M
Smith
Brian R
BR
Lewis
Kayan L
KL
Coughlin
Steven S
SS
Gossman
Ginger L
GL
McDonald
Jill A
JA
Foulkes
Hillary
H
Mirchandani
Gita
G
Correa-Nieto Canedo
Luz
L
Garcia
Imelda M
IM
Acuña
Juan
J
D003430:Cross-Sectional Studies; D004087:Dihydroergotamine; D004493:Education; D005260:Female; D015438:Health Behavior; D007722:Health Knowledge, Attitudes, Practice; D006630:Hispanic or Latino; D006801:Humans; D008800:Mexico; D015999:Multivariate Analysis; D065006:Papanicolaou Test; D036801:Parturition; D011247:Pregnancy; D011295:Prenatal Care; D012959:Socioeconomic Factors; D013781:Texas; D002583:Uterine Cervical Neoplasms / Q000175:diagnosis*; D014626:Vaginal Smears; D014932:Women's Health Services / Q000458:organization & administration*
D004087:Dihydroergotamine
Health Care Women Int. 2007 Oct;28(9):799-816
17907008
Ethn Dis. 2007 Winter;17(1):129-34
17274222
J Natl Cancer Inst. 2002 Oct 2;94(19):1469-83
12359856
Arch Med Res. 1998 Autumn;29(3):263-70
9775462
Cancer Causes Control. 1997 Sep;8(5):698-704
9328191
CA Cancer J Clin. 2002 Nov-Dec;52(6):342-62
12469763
Int J Cancer. 2008 Jul 1;123(1):153-60
18404671
Am Fam Physician. 2005 Apr 1;71(7):1307-16
15832534
Obstet Gynecol. 1998 Nov;92(5):873-7
9794686
Ethn Health. 2007 Jun;12(3):245-63
17454099
Salud Publica Mex. 2003;45 Suppl 3:S315-25
14746024
Prev Chronic Dis. 2008 Oct;5(4):A120
18793508
JAMA. 2001 Jun 27;285(24):3107-15
11427139
Int J Gynecol Cancer. 2002 Sep-Oct;12(5):475-9
12366665
Salud Publica Mex. 2008 Mar-Apr;50(2):107-18
18372991
BMC Health Serv Res. 2007 Jan 23;7:10
17244348
Int J Gynaecol Obstet. 2005 May;89 Suppl 2:S21-9
15823263
Obstet Gynecol. 1997 Oct;90(4 Pt 1):634-6
9380330
N Engl J Med. 2005 Nov 17;353(20):2158-68
16291985
Bull World Health Organ. 2001;79(10):954-62
11693978
J Community Health. 2003 Oct;28(5):317-33
14535598
Fam Community Health. 2003 Apr-Jun;26(2):130-9
12802118
Prev Med. 2004 Feb;38(2):192-7
14715211